MAX-002

Thuốc Gốc

Small Molecule

MAX-002 is developed by Axcan, consisits of, 1-gram mesalamine suppository for the treatment of ulcerative proctitis.

Cơ Chế Tác Dụng : MAX-002 is developed by Axcan, consisits of, 1-gram mesalamine suppository for the treatment of ulcerative proctitis. MAX-002 is improved formulation of the CANASA 1 gram suppository which provides several key advantages, including size, as it is 25% smaller than the current formulation. it improves patients' compliance and quality of life, as patients should find MAX-002 more comfortable than CANASA. Consequently, MAX-002 should have a positive impact on treatment compliance, while providing the safety and efficacy patients expect from this product.

Chỉ Định : Investigated for use/treatment in inflammatory bowel disease.

Tài Liệu Tham Khảo Thêm

drugbank

http://www.drugbank.ca/drugs/DB05376

Bạn thấy hài lòng ?

Bạn chưa hài lòng ?

... loading